Arrowstreet Capital, Limited Partnership Bausch Health Companies Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $136 Billion
- Q2 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,759,951 shares of BHC stock, worth $12.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,759,951
Previous 4,324,226
59.3%
Holding current value
$12.3 Million
Previous $28 Million
58.1%
% of portfolio
0.01%
Previous 0.02%
Shares
24 transactions
Others Institutions Holding BHC
# of Institutions
252Shares Held
243MCall Options Held
2.44MPut Options Held
8.42M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$243 Million2.99% of portfolio
-
Goldentree Asset Management LP New York, NY34.3MShares$240 Million23.91% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny32.8MShares$230 Million11.35% of portfolio
-
Nomura Holdings Inc Tokyo, M021.5MShares$150 Million0.31% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$91 Million0.18% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.53B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...